Chief Executive Officer, Rubius Therapeutics.
Dr. Pablo Cagnoni
Dr. Pablo Cagnoni has served on our Board of Directors since December 2015. Pablo currently serves as Chief Executive Officer of Rubius Therapeutics, where he joined in June 2018. He previously served as President and Chief Executive Officer of Tizona Pharmaceuticals from May 2015 to June 2018. Before that, Pablo was President of Onyx Pharmaceuticals from October 2013 to April 2015, and Executive Vice President, Global Research and Development and Technical Operations from April 2013 to October 2013. He has also served in senior management roles at Novartis, Allos Therapeutics and OSI Pharmaceuticals. Pablo was also Assistant Professor of Medicine and Assistant Director Pharmacology Laboratory at the University of Colorado Bone Marrow Transplant Program. He received an M.D. from the University of Buenos Aires School of Medicine and completed fellowships in Hematology and Oncology at the Mount Sinai Medical Center and in Stem Cell Transplantation at the University of Colorado Health Sciences Center.